Male mice engineered to overexpress transgenic XIST are prone to autoimmunity, developing severe multiorgan pathology after transgenic XIST induction as well as autoantibodies against XIST–RNP complexes (Dou et al, 2024). The gene discussed is XIST; the disease is Autoimmunity.